Submissions from 2023
Evaluation of Four-Factor Prothrombin Complex Concentrate Dosing Strategies for the Reversal of Bleeding Associated with Apixaban or Rivaroxaban, Paolo A. Scalla, Heidi Clarke, Erika Dittmar, and Thomas Wolfel
Evaluation of pharmacist intervention on spontaneous awakening trials (SAT) in ventilated patients, Natalie Quesep, Delany Santos Ferrer, and Heidi Clarke
Evaluation of the Impact of an Antibiotic Time-out for Transition of IV Vancomycin to Oral Linezolid in Hospitalized Patients, Mary S. Vogel, Jefferson Cua, Erika Dittmar, and Kelsey N. Williams
Impact of a pharmacist-driven carbapenem de-escalation algorithm for hospitalized patients with urinary tract infections, Susana Diaz, Jefferson Cua, Kelsey Williams, Erika Dittmar, and Timothy P. Gauthier
Implementation of 4T score documentation on PF4 testing in patients with Suspected heparin induced thrombocytopenia (HIT), Maria A. Ruiz, Jessica Justiz, Radhan Gopalani, Heidi Clarke, and Erika Dittmar
Implementation of a Pharmacist-Driven Quetiapine Taper in Acutely Delirious Critically Ill Patients, Allison Vargas
Pharmacist-led Care in Collaboration with a Cardiovascular Team to Improve the Management of Atherosclerotic Heart Disease Risk in Hospitalized Patients, Radhan B. Gopalani, Dayana Martinez, Maura Falli, Kristen de Almeida, Jody Murray, Lisa K. Davis, Adedapo Iluyomade, Tarak S. Rambhatla, and Jonathan A. Fialkow
Submissions from 2022
Assessment of fixed-schedule versus symptom-triggered benzodiazepine prescribing patterns for prevention of alcohol withdrawal syndrome in ICU patients, Maria A. Mosello, Mary Vogel, Heidi Clarke, Erika Dittmar, and Michael Pasqualicchio
Evaluation of a 3% Hypertonic Saline Protocol for the Management of Hyponatremia, Susana Diaz, Paolo Scalla, Jessica Greenwood, Jonathan Kline, and Heidi Clarke
Impact of Midodrine on Optimization of Beta-blocker Therapy in Heart Failure with Reduced Ejection Fraction Patients, Radhan Gopalani, Maura Falli, Dayana Rodriguez Requena, and Kristen de Almeida
New Drug Approvals in Cardiology, Giselle Chahili and Radhan B. Gopalani
Preceptor Development: Feedback & Evaluation, Radhan B. Gopalani and Faaria Quadri
Timely waste and order discontinuation of continuous intravenous controlled medications: Impact of a process improvement project, Frank C. Moreno Exposito, Esty Tremino, Heidi Clarke, Jonathan Kline, and Payal Patel
Review of Direct Oral Anticoagulant Agents, Radhan B. Gopalani
Assessment of Clinical and Safety Outcomes of Bivalirudin versus Heparin in Patients Undergoing Percutaneous Coronary Intervention, Radhan B. Gopalani, Giselle Chahili, and Payal Patel
Assessment of infliximab use in hospitalized patients, Manny Alfonso, Erika Dittmar, and Radhan Gopalani
Implementation of a conversion from intravenous alteplase to tenecteplase for treatment of acute ischemic stroke, Lourdes R. Menendez, Erika Dittmar, Felipe De Los Rios La Rosa, Star Belnap, Maygret Ramirez, and Thomas Wolfel
Evaluation of Anti-Factor Xa Level Usage for Low Molecular Weight Heparin in a Healthcare System, Natalie Quesep, Lourdes R. Menendez, Erika Dittmar, Radhan Gopalani, and Payal Patel
Validating Controlled Substances, Manny Alfonso
Are Pharmacists Up to Speed?: Pharmacy Driven Initiatives, Allison Vargas
Steroids Debate: Indication, Dosing, and Duration of Therapy, Frank C. Moreno Exposito
Submissions from 2021
Assessment of Recombinant Factor VIIa Prescribing Patterns and Clinical Outcomes in a Healthcare System, Giselle Chahili, Radhan B. Gopalani, Kristen de Almeida, and Maura Falli
CHALLENGES IN THE MANAGEMENT OF MIXED CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY HYPERTENSION AND CARDIOGENIC SHOCK, Laura Neubauer and Sandra Chaparro
Evaluation and optimization of medication related fall risk at a community hospital, Giselle Chahili, Thomas Wolfel, Heidi Clarke, and Erika Dittmar
Evaluation of an elevated VTE thromboprophylaxis guideline for critically ill patients infected with COVID-19, Tony Nguyen and Heidi Clarke